Leone RD - Search Results

1

A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy.

Leone RD, Lo YC, Powell JD. Leone RD, et al. Comput Struct Biotechnol J. 2015 Apr 8;13:265-72. doi: 10.1016/j.csbj.2015.03.008. eCollection 2015. Comput Struct Biotechnol J. 2015. PMID: 25941561 Free PMC article. Review.

2

Something in the air: hyperoxic conditioning of the tumor microenvironment for enhanced immunotherapy.

Leone RD, Horton MR, Powell JD. Leone RD, et al. Cancer Cell. 2015 Apr 13;27(4):435-6. doi: 10.1016/j.ccell.2015.03.014. Cancer Cell. 2015. PMID: 25873169 Free PMC article.

3

Targeting adenosine for cancer immunotherapy.

Leone RD, Emens LA. Leone RD, et al. J Immunother Cancer. 2018 Jun 18;6(1):57. doi: 10.1186/s40425-018-0360-8. J Immunother Cancer. 2018. PMID: 29914571 Free PMC article. Review.

4

Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models.

Leone RD, Sun IM, Oh MH, Sun IH, Wen J, Englert J, Powell JD. Leone RD, et al. Cancer Immunol Immunother. 2018 Aug;67(8):1271-1284. doi: 10.1007/s00262-018-2186-0. Epub 2018 Jun 19. Cancer Immunol Immunother. 2018. PMID: 29923026

5

Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion.

Leone RD, Zhao L, Englert JM, Sun IM, Oh MH, Sun IH, Arwood ML, Bettencourt IA, Patel CH, Wen J, Tam A, Blosser RL, Prchalova E, Alt J, Rais R, Slusher BS, Powell JD. Leone RD, et al. Science. 2019 Nov 22;366(6468):1013-1021. doi: 10.1126/science.aav2588. Epub 2019 Nov 7. Science. 2019. PMID: 31699883 Free PMC article.

6

Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells.

Oh MH, Sun IH, Zhao L, Leone RD, Sun IM, Xu W, Collins SL, Tam AJ, Blosser RL, Patel CH, Englert JM, Arwood ML, Wen J, Chan-Li Y, Tenora L, Majer P, Rais R, Slusher BS, Horton MR, Powell JD. Oh MH, et al. Among authors: leone rd. J Clin Invest. 2020 Jul 1;130(7):3865-3884. doi: 10.1172/JCI131859. J Clin Invest. 2020. PMID: 32324593 Free PMC article.

7

Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy.

Leone RD, Powell JD. Leone RD, et al. Cancer Immunol Res. 2021 Mar;9(3):255-260. doi: 10.1158/2326-6066.CIR-20-0791. Cancer Immunol Res. 2021. PMID: 33648947 Free PMC article. Review.

8

Targeting metabolism to regulate immune responses in autoimmunity and cancer.

Patel CH, Leone RD, Horton MR, Powell JD. Patel CH, et al. Among authors: leone rd. Nat Rev Drug Discov. 2019 Sep;18(9):669-688. doi: 10.1038/s41573-019-0032-5. Epub 2019 Jul 30. Nat Rev Drug Discov. 2019. PMID: 31363227 Review.

9

Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.

Rangwala R, Leone R, Chang YC, Fecher LA, Schuchter LM, Kramer A, Tan KS, Heitjan DF, Rodgers G, Gallagher M, Piao S, Troxel AB, Evans TL, DeMichele AM, Nathanson KL, O'Dwyer PJ, Kaiser J, Pontiggia L, Davis LE, Amaravadi RK. Rangwala R, et al. Autophagy. 2014 Aug;10(8):1369-79. doi: 10.4161/auto.29118. Epub 2014 May 20. Autophagy. 2014. PMID: 24991839 Free PMC article. Clinical Trial.

10

Autophagy: a targetable linchpin of cancer cell metabolism.

Leone RD, Amaravadi RK. Leone RD, et al. Trends Endocrinol Metab. 2013 Apr;24(4):209-17. doi: 10.1016/j.tem.2013.01.008. Epub 2013 Mar 6. Trends Endocrinol Metab. 2013. PMID: 23474062 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results